it is called investors realizing that the company's commercial strategy... playing the drug-give-away game in order to hopefully one day reverse the gross-to-nets, especially in a highly-competitive and genericized market.. is similar to the titanic sailing directly into an iceberg
Lots of insider selling right before a PDUFA date... https://www.themarketsdaily.com/2018/10/12/therapeuticsmd-inc-txmd-insider-john-c-k-iv-milligan-sells-250000-shares-of-stock.html https://www.themarketsdaily.com/2018/10/11/therapeuticsmd-inc-txmd-director-brian-bernick-sells-91400-shares.html
How are we supposed to make any money on this friggin stock if founders keep exercising options and are not repurchasing shares? The stock price is going to continue to drop and we all lose money
stockholders are drowning. You have a responsibility to your shareholders. Throw us a g*d damn life vest and sell the freaking company or buy back some shares already
another red day even on good news rob finizio. Only way to make money on this is to sell the company. Take the guaranteed money rob
should have kept the company privately owned. I have lost so much money investing in this company. Only a buyout would help me now. Thanks rob
You know I am new to TherapeuticsMD but have been in the life science industry for 20+ years. TXMD's market cap seems so shockingly low considering the potential of your 3 new products. For example I know of a 23 year old who has been using NuvaRing for 2-3 years but cannot wait to switch to Annovera. There appears no question Annovera will do well. However, to someone on the outside it seems like Bijuva especially is a clinical break through and potential blockbuster (as in $1 billion/year/sales). Without giving confidential information away, can someone tell us if HCPs/patients truly see the value proposition in Bijuva...even better if you can point to a link somewhere where HCP's comment on Bijuva? I promise I am not with TXMD management nor a competitor...just a supervisor in quality assurance at a small biotech in New Jersey...but more important a parent of 3 children that sees buying TXMD stock as a good idea if I were to hold for a couple of years. Is Bijuva real? Thank you in advance for any sincere and genuine feedback.
bijuva is basically a mixture of two products patients are already paying for, which is being compounded by pharmacies without fda approval. With Bijuva, patients will pay a lower price for those two products, which is created with an fda approved process. It’s a no brainer Which leads me to the original question, wtf is up with the stock price? It’s down 66 percent from where it was a few months ago. Sell the company rob. Uphold your responsibility to the shareholders and salvage this damn thing. We are drowning
